Articles

HUB programs ensure that cancer care is delivered efficiently. However, many patients and healthcare providers need more education on the services offered for these programs to be effective. In this session, experts discuss common challenges of HUB programs and the future of these support services. Read More ›

The COVID-19 pandemic exposed many cracks in today’s healthcare system, including underrepresentation of minorities in clinical trials. In this session, experts discuss this important issue, as well as strategies for effectively breaking down current health equity barriers. Read More ›

The COVID-19 pandemic has allowed telemedicine to be widely adopted for the delivery of cancer care. In this session, experts discuss some of the benefits of this technology, as well as key legal issues that need to be addressed. Read More ›

The COVID-19 pandemic has significantly affected all areas of the healthcare system. In this session, experts offer pharmaceutical perspectives on the innovations that may result from the current public health crisis and the future of cancer care. Read More ›

Cancer Centers of Excellence play an important role in the delivery of cancer care. Future expansion into the communities and remotely will benefit patients, employers, and payers, and may help to close health disparity gaps. Read More ›

From the CMS’s Oncology Care Model to future prospects for Oncology Care First and other value-based and alternative payment models, payers share their insights on what is most likely to succeed to improve care and manage costs in oncology. Read More ›

From quality-adjusted life-years to social determinants of health to the international pricing index, top experts in cancer care economics discussed strategies for achieving the Holy Grail of true value-based pricing for pharmaceuticals. Read More ›

From new approaches for sequencing therapy to preparing for an incoming tsunami of delayed diagnoses after months of missed cancer screenings, community cancer providers have a lot to manage in the era of COVID-19. Read More ›

Greg Simon, who led the Cancer Moonshot program under the Obama-Biden administration, asserts that the COVID-19 pandemic has exposed vast chasms of inequity in cancer care, and challenges listeners to think in new ways about how we deliver and pay for care. Read More ›

Uncertainty reigns in Washington with the upcoming election only weeks away. What can cancer care stakeholders expect from legislators and policymakers over the next several weeks, during the lame duck session, and in 2021? Read More ›